Monoamine oxidase inhibition: possible mechanism for cyproheptadine-induced alterations in insulin secretion.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D006224:Cricetinae; D003533:Cyproheptadine / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008647:Mesocricetus; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology
D001786:Blood Glucose; D006634:Histamine H1 Antagonists; D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D003533:Cyproheptadine; D012701:Serotonin; D006916:5-Hydroxytryptophan; D008995:Monoamine Oxidase; D005947:Glucose